4,4,5,5-Tetramethyl-2-[10-(1-naphthyl)anthracen-9-yl]-1,3,2-dioxaborolane, 99%, 5g

7-Bromo-4,5-dihydro-1H-pyrido[2,3-e][1,4]diazepin-2(3H)-one, 95.0%, 250mg

(4-Butoxy-3-chlorophenyl)boronic acid, 95.0%, 5g

5-Bromo-2'-deoxyuridine, 95.0%, 10g

5-(2-chlorophenyl)-2-furaldehyde, 95.0%, 1g

(R)-tert-Butyl 3-(2-nitrophenoxy)pyrrolidine-1-carboxylate, 95.0%, 1g

Nalpha-(5-Fluoro-2,4-dinitrophenyl)-D-leucinamide [HPLC Labeling Reagent for e.e. Determination]>98.0%(HPLC)100mg

2-Amino-5-bromo-3-methoxybenzoic acid, 95.0%, 100g

3-ethyl-5-hydroxyadamantane-1-carboxylic acid, 95.0%, 1g

Methyl 2,5-dioxo-2,5-dihydro-1H-pyrrole-1-carboxylate, 95.0%, 25g

ethyl 4-(2,5-dimethylphenyl)-2-hydroxy-4-oxobut-2-enoate, 95%, 2.5g

(5-Chloro-2-fluorophenyl)acetic acid ethyl ester, 97.0%, 1g

7-FLUORO-1,1-DIMETHYL-1H-INDEN-5-YL-AMINE, 95.0%, 250mg